Biopharmaceutics
GIT- Barriers to Drug Absorption (and Mechanisms of Drug absorption)
Lec:3
Ali Y Ali BSc Pharmacy
MSc Industrial Pharmaceutical Sciences
Dept. of Pharmaceutics College of Pharmacy
University of Sulaimani
Overview Barriers to drug absorption• Environment within the GIT
• GIT pH• Luminal Enzymes • Food inside the GIT • Disease state and physiological conditions
• Unstirred water layer • GIT membrane
• Structure of Membrane • Mechanisms of drug absorption
• Transcellular • Paracellular • Efflux of drugs from GIT
• Presystemic Metabolism • Gut wall • Hepatic
15/11/2019 2
Barriers to Drug absorption
15/11/2019 3
http://www.hilmersstudios.com/medical
Environment within GIT 1. GIT pH
2. Luminal Enzymes
3. Food inside the GIT
4. Disease state and physiological conditions
15/11/2019 4
Gastrointestinal (GIT) pH
• It varies along the GIT
• Stomach: • Fasted state: 1-3.5
15/11/2019 5http://www.open.edu/openlearnworks/mod/oucontent/view.php?id=288§ion=1.4.2#back_thumbnail_idm36324752
GIT pH• Fed state: the gastric juice is buffered
to a less acidic depending on the food composition pH 3-7.
• The cycles returns to the fasted pH after 2-3 hours, depending on the size of the meal
• Only dosage forms taken during or straight after meal will encounter this.
15/11/2019 6
pH 3-7
• Intestinal pH: • Higher than gastric juice
owing to pancreatic secretion of bicarbonate • Gradual increase from
duodenum to ileum
• Colon:• pH drops again
15/11/2019 7
Effects of pH
Effects
Chemical Stability
Rate and Extent of
Dissolution
15/11/2019 8
Chemical Stability
• pH dependent hydrolysis • Penicillin G( Benzyl penicillin)
• Penicillin G degradation in the stomach depends on • GER
• Gastric pH
15/11/2019 9
Erythromycin
• Erythromycin rapidly degraded
• Prodrug
• Gastro-resistant tablet
15/11/2019 10
Proton Pump Inhibitors • Omeprazole & Esomeprazole• used in the treatment of peptic
ulcers.
• Enteric coated tablet
15/11/2019 11
Luminal Enzymes
• Gastric juice:• Pepsin;
• protein and peptide drugs undergo decomposition
• Intestinal:• Lipases: release of drug that has fat/oil containing dosage forms • Proteases• Amylases • Drug of nucleotide and fatty acid bases or containing esters – hydrolysis
15/11/2019 12
Colon:• Bacteria producing enzymes e.g. azo-reductase
• This enzyme has been exploited for the design of prodrugs • Sulfasalazine: 5ASA---Azo---- Salazopyridine
15/11/2019 13
Food inside the GIT 1. Complexation with components in the food 2. Alteration of pH 3. Alteration of GER 4. Stimulation of GIT secretions 5. Competition between food components and
drugs for specialised absorption mechanisms 6. Increased viscosity of the GIT contents 7. Food induced changes in presystemic
metabolism 8. Food induced changes in the blood flow
15/11/2019 14
`1. Complexation with components in the food • reversible water soluble complexes are not problematic • Irreversible complex, reduction of the amount of the drug
available for absorption• e.g. Tetracyclines forms non absorbable complex with
Calcium and Iron ions
• It is not taken with milk and Iron preparations
15/11/2019 15
2. Alteration of pH: increase gastric pH by acting as a buffer• Dissolution of Weakly basic drugs reduced, however of acidic
drugs increased.
3. Alteration of GER: • Fat containing foods reduce GER
15/11/2019 16
4.Stimulation of GIT secretions: Gastric secretions (Pepsin) and bile. • Bile: surface active agent, forms insoluble complex
• Neomycin
5. Competition between food components and drugs for specialisedabsorption mechanisms
15/11/2019 17
6. Increased viscosity of the GIT contents:
• Dissolution reduced • Diffusion from lumen to the membrane reduced
7. Food-induced changes in presystemic metabolism :• Grapefruit juice: inhibit metabolic enzymes.• Increase bioavailability of drugs undergo metabolism • verapamil, ciclosporin
15/11/2019 18
8. Food induced changes in the blood flow• Increase blood flow • Rate of presentation to the liver • Drugs metabolised by liver; bioavailability increased • Saturation of the enzymes • Propranolol & Hydralazine
15/11/2019 19
Effects of Food on absorption
15/11/2019 20
Disease state and physiological disorders
• Local disease:• alteration in pH –stability and dissolution
• Gasterectomy: surgical removal of part or whole stomach, faster presentation of drugs to intestine.
1. Drugs absorbed from intestine: higher bioavailability 2. Drugs needs dissolution in the stomach: reduced bioavailability
15/11/2019 21
Disease state and physiological disorders
• AIDS patients
• Hypochlorhydria
• Adversely affect the dissolution and hence bioavailability of weakly basic drugs • anti-fungal ketoconazole
15/11/2019 22
Coeliac disease
• Inflammatory disease affecting the proximal small intestine
• Gluten, protein found in cereals and grains
• Patients with coeliac disease 1. Faster GER 2. Increased permeability of the small intestine
• Cephalexin absorption appears to be increased in celiac disease
Unstirred water layer
• Mucus, water, glycocalyx • 30-100 µm thickness
1. Diffusion barrier 2. Complexation with mucus
15/11/2019 24
GIT membrane
• Structure of Membrane
• Mechanisms of drug absorption
15/11/2019 25
Structure of membrane
• The main cellular barrier for absorption. • Complex: protein, lipid, lipoproteins and polysaccharide.
15/11/2019 26
Structure of membrane • Semi-permeable membrane• Permeable: amino acids, fatty acids and sugars
• Impermeable: plasma proteins
• Semi-permeable sieve: allows lipid-soluble molecules across it and the hydrophilic molecules and water will be transported through the pores
15/11/2019 27
• Transporter proteins and carrier molecules that transport materials back and forth.
Mechanisms of transport across the membrane
1. Transcellular: across the cells 1. Passive diffusion 2. Carrier mediated
transport 3. Endocytosis
2. Paracellular: between cells
15/11/2019 28
Mechanisms of transport across the membrane• Passive
• Active
15/11/2019 29
Passive diffusion • Most drugs absorbed
• Movement of moleculesacross a semi-permeable membrane from a region of high concentration to a region of lower concentration.
15/11/2019 30
Rate of Diffusion
1. Physicochemical properties• Lipid solubility
2. Nature of the membrane
3. Concentration gradient • Dissolution • Sink condition
15/11/2019 31
Passive diffusion • Fick’s First Law of diffusion
• dC/dt: rate of appearance of drug in the blood at the absorption site • P : permeability coefficient • Cg: concentration of the drug in solution in the GIT fluid at the absorption site • Cb: concentration of the drug in the blood at the absorption site
15/11/2019 32
𝑑𝐶𝑑𝑡
= 𝑃(𝐶' − 𝐶))
• D: diffusion coefficient of the drug in the GIT• A: surface area of membrane • K: partition coefficient • h : thickness of the wall
15/11/2019 33
𝑃 =𝐷 𝐴 𝐾ℎ
Rate of diffusion
1. Diffusion coefficient (D)
2. Surface area of absorption (A): • Small intestine is the major site of absorption
3. Partition coefficient (K)
4. Thickness of the wall (h)
5. Concentration gradient (Cg-Cb)
15/11/2019 34
𝑑𝐶𝑑𝑡
=𝐷 𝐴 𝐾ℎ
(𝐶' − 𝐶))
• Partition coefficient of the drug from GIT fluid to the membrane
• Partition coefficient of the drug from the membrane to the blood
15/11/2019 35
Partitioning
Passive diffusion stops after balance ?
• The concentration gradient is kept at the site of the absorption by the blood which acts as a ‘sink’ • Distribution • Metabolism • Excretion • Protein binding
15/11/2019 36
Sink Condition
• All these makes Cg >>>> C b
15/11/2019 37
𝑑𝐶𝑑𝑡
= 𝑃(𝐶' − 𝐶))𝑑𝐶𝑑𝑡
= 𝑃(𝐶' − 0 )
Sink Condition
• D, A,K and h can be considered as constant P
15/11/2019 38
𝑑𝐶𝑑𝑡
=𝐷 𝐴 𝐾ℎ
(𝐶')
𝑑𝐶𝑑𝑡
= 𝑃 𝐶'
Passive diffusion
• The process follows first order kinetics
• Drugs are weak electrolytes so undergo dissociation based on theirpKa and pH of the environment in to ionised and unionised forms.
• Unionised is more lipophilic so more permeable form.
• Hence the rate of absorption is dependent on the concentration of the unionised form.
15/11/2019 39
Ionization
• Acids
• Bases
Example
• Salicylic acid pKa is 3
a. Gastric Juice : pH = 1.2
a. Plasma : pH = 7.4
Examples
15/11/2019 42
Carrier-Mediated transport
1. Active transport
2. Facilitated diffusion
15/11/2019 43
Active Transport
• Mechanism of transport of drugs which involves carrier molecules and use of energy by cells in form of ATP.
• It can be from a lower concentration to a higher concentration.
15/11/2019 44
Active Transport
15/11/2019 45
The process of Active Transport
Carrier or transporters involved 1. Structure specificity:
• Competition between structurally similar molecules (drugs)
2. Energy is used: metabolic inhibitors will reduce the process
3. Saturable
15/11/2019 46
Site of the Carriers
• Carriers are concentrated in a certain place in the GIT: • Bile salt transporters are condensed and located in the ileum
15/11/2019 47
Passive Vs Activated Transport
15/11/2019 48
Transporters• Peptide • Nucleoside • Sugar • Amino acid• Bile acid • Organic anions • Vitamins: Thiamin B1, nicotinic acid, Riboflavin B2,
Pyridoxine B6, cobalamin B12
15/11/2019 49
Transporters
• Peptide like drugs: Penicillins, cephalosporins, ACE inhibitors
• Nucleoside analogues: antivirals
• Amino acid : L-Dopa and methyldopa• L-Dopa has faster permeability due to the lower affinity of the methyl dopa to
the transporters
15/11/2019 50
Facilitated Diffusion
• Carrier mediated • Saturable process • It is not against concentration gradient • It does not use energy
• Minor role in drug absorption
15/11/2019 51
Endocytosis (Vesicular Transport )
• Is the process in which the cell membrane invaginates and surrounds a certain material, this invagination forms vesicles.
• Then the material will be transferred to other vesicles or to lysosome for digestion
15/11/2019 52
Endocytosis
• Some materials escape digestion and exocytosed.
• Energy dependent
• Macromolecules
15/11/2019 53
Types
1.Pinocytosis (fluid-phase endocytosis)
• Engulfment of the extracellular fluid by membrane vesicles, the internalization is regardless of its importance to cells.
• Vitamins E, D, A, K.
15/11/2019 54
2. Receptor mediated endocytosis
• Receptors on the cell surface
• The vesicles end up in the lysosomes where is a place of digestion
15/11/2019 55
3.Phagocytosis: particles > 500 nanometre• Vaccines
• Polio vaccine
4. Transcytosis: material is internalized and transferred across the cell to the other side of the cell.
15/11/2019 56
500 nm
Absorption through the Lymphatic System
• Lipophilic drugs may be absorbed through the lacteal or lymphatic vessels
• The lymphatics are important in the absorption of dietary lipids • Partially responsible for the absorption of lipophilic
drugs
• The lymphatic system bypasses the liver and avoids the first-pass effect • Lymphatic vessels drain into the vena cava rather than
the hepatic-portal vein.
Absorption through the Lymphatic System
• Many poorly water-soluble drugs are soluble in oil and lipids• May dissolve in chylomicrons and be absorbed systemically via the lymphatic
system.
• Examples • Bleomycin was prepared in chylomicrons to improve oral absorption through the
lymphatic system (Yoshikawa et al, 1983, 1989). • Testosterones
Paracellular Pathway • Transport through aqueous pores between
the cells.
• They occupy only 0.01 % of the total surface area of epithelium.
• Tightness of junctions vary• Small intestine is leakier.
15/11/2019 59
Paracellular Pathway
• Small hydrophilic and charged drug can be absorbed when they cannot be absorbed transcellularly.
• 200 Dalton
• Passive diffusion or convective
15/11/2019 60
• Ions, sugars, amino acids and peptides above capacity of carriers.
15/11/2019 61
Efflux of drugs from the intestine • Counter transport efflux proteins that
expels drug back into the GIT lumen
• P-glycoprotein : expressed at high levels in jejunum.
• Bioavailability reduction
• Similar mechanism of active transport
15/11/2019 62
Efflux of drugs from the intestine
• Energy required
• Against concentration gradient
• Saturable process and can be competitively inhibited
15/11/2019 63
Presystemic Metabolism • First-pass metabolism• Cytochrome CYP P450
1. Gut wall
2. Hepatic
15/11/2019 64
Presystemic Metabolism • Primary site of metabolism
• Considerable reduction in Bioavailability• Oral ineffective • Vey large dose compared to IV,
Propranolol
• Propranolol is well absorbed• only 30% available
• Lidocaine• Imipramine (TCA)
15/11/2019 65
Barriers to Drug absorption
15/11/2019 66
Further Readings • Aulton, M. E. and K. M. Taylor (2013). Aulton's pharmaceutics: the design
and manufacture of medicines, Elsevier Health Sciences.• Shargel, L., S. Wu-Pong and A. B. Yu (2007). Applied biopharmaceutics &
pharmacokinetics, McGraw-Hill.• Fleisher, D., B. Sweet, A. Parekh and J. Boullata (2010). Drug Absorption with
Food. Handbook of Drug-Nutrient Interactions. J. I. Boullata and V. T. Armenti, Humana Press: 209-241.• Lake-Bakaar G, Tom W, Lake-Bakaar D, Gupta N, Beidas S, Elsakr M, et al.
Gastropathy and ketoconazole malabsorption in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1988;109(6):471-3.
15/11/2019 67
Videos
• https://www.youtube.com/watch?v=IOf-z0D1mHk• https://www.youtube.com/watch?v=xiuWdJYyIKs• https://www.youtube.com/watch?v=uej8IDhjvZg
15/11/2019 68